Fibroblast Growth Factor 8: A Key Regulator in Human Development and Disease
en-GBde-DEes-ESfr-FR

Fibroblast Growth Factor 8: A Key Regulator in Human Development and Disease

19/06/2025 Compuscript Ltd

The role of Fibroblast Growth Factor 8 (FGF8) in embryonic development and organ formation is gaining increased recognition as scientists uncover its wide-ranging influence. FGF8, a powerful signaling molecule, is essential for orchestrating the growth and differentiation of multiple tissues, including craniofacial structures, limbs, internal organs, and the brain. Any disruption in its function can lead to developmental disorders, highlighting its critical importance in normal growth processes.

During early organogenesis, FGF8 controls the proliferation, migration, and differentiation of stem cells, guiding the formation of key anatomical features. It plays a pivotal role in craniofacial development, ensuring the proper formation of the jaw, palate, and other skeletal structures. Abnormal FGF8 activity has been associated with skeletal malformations, including cleft palate and craniofacial syndromes.

FGF8 is also central to limb formation, directing patterning and segmentation to ensure normal growth of the arms and legs. Disruptions in its signaling pathway have been linked to limb malformations, such as split hand/foot malformation and limb asymmetry. Research further underscores its role in kidney development, where it regulates nephron formation and organ function, with defects potentially leading to renal abnormalities and congenital kidney disorders.
In cardiac development, FGF8 is required for the formation of the heart and great vessels, influencing processes such as outflow tract remodeling and valve formation. Dysregulation of FGF8 has been implicated in congenital heart defects, including persistent truncus arteriosus and outflow tract malformations, which can lead to severe cardiovascular conditions.

The nervous system is another area where FGF8 exerts profound effects. It governs the development of key brain structures, including the forebrain, midbrain, and hindbrain, playing a crucial role in neuronal differentiation and connectivity. Variations in FGF8 expression have been associated with neurodevelopmental disorders, such as Kallmann syndrome, holoprosencephaly, and CHARGE syndrome, which impact cognitive function, sensory processing, and neuroendocrine signaling.

With its far-reaching impact, FGF8 is a key focus in the field of developmental biology and regenerative medicine. Understanding its precise mechanisms could lead to targeted therapeutic strategies for treating congenital anomalies and tissue regeneration. As advancements in gene editing and molecular medicine continue to evolve, FGF8 remains a critical factor in unlocking the complexities of human growth and disease prevention.

# # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 8.4
Impact Factor: 6.9

# # # # # #

More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases ).
Submissions to Genes & Disease may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx ).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.com
X (formerly Twitter): @GenesNDiseases (https://x.com/GenesNDiseases )

# # # # # #
Reference
Huamin Yin, Lian Duan, Zhendong Wang, Li Liu, Jingling Shen, Fibroblast growth factor 8: Multifaceted role in development and developmental disorder, Genes & Diseases, Volume 12, Issue 5, 2025, 101524, https://doi.org/10.1016/j.gendis.2025.101524

Funding Information:
National Natural Science Foundation of China 81701350
National Natural Science Foundation of China 31671252
Health Technology Plan of Zhejiang Province 2023RC205
Zhejiang Provincial Natural Science Foundation of China LQ22C120002

Huamin Yin, Lian Duan, Zhendong Wang, Li Liu, Jingling Shen, Fibroblast growth factor 8: Multifaceted role in development and developmental disorder, Genes & Diseases, Volume 12, Issue 5, 2025, 101524, https://doi.org/10.1016/j.gendis.2025.101524
Attached files
  • FGF8 assumes a pivotal role in the process of mammalian growth and development.
  • The human and mouse expression profile of FGF8. (A) Relative abundance of FGF8 in adult human tissues from the Genotype-Tissue Expression (GTEx V8) Project Consortium (TPM, transcripts per million reads)..
19/06/2025 Compuscript Ltd
Regions: Europe, Ireland, Asia, China
Keywords: Health, Medical, People in health research, Science, Life Sciences, People in science

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement